Vorasidenib and grading of IDH mutant astrocytoma

Neuro-Oncology: The Podcast

English - October 27, 2023 12:54 - 24 minutes - 22.2 MB - ★★★★★ - 9 ratings
Medicine Health & Fitness Science Life Sciences brain oncology tumors glioblastoma glioma lymphoma neurology neurooncology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Insulin feedback and PI3K inhibition in GBM

Next Episode: Brain-tumor related epilepsy; a SNO consensus review

Description: Dr. Ankush Bhatia interviews Dr. Matthias Preusser about the recent letter in Neuro-Oncology, entitled: "What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?", published in July 2023.